Patent Application for Dichrostachys glomerata Health Benefits
Summary
The USPTO has published a patent application (US20260083794A1) detailing methods and compositions using Dichrostachys glomerata for various health benefits, including reducing anxiety and improving mood. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.
What changed
This document is a USPTO patent application (US20260083794A1) for methods and compositions utilizing Dichrostachys glomerata to achieve health and wellness benefits in mammals. Specifically, the application claims efficacy in reducing anxiety, food cravings, and stress, while improving mood, physical and mental health, energy, and happiness. The described compositions are intended for oral administration in forms such as pills, capsules, liquids, lozenges, or tablets.
As this is a patent application, it does not impose immediate regulatory obligations. However, it signals potential future developments in therapeutic products derived from Dichrostachys glomerata. Companies involved in the development or manufacturing of natural health products, pharmaceuticals, or dietary supplements should monitor the progress of this patent application and related intellectual property developments in this area.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS AND COMPOSITIONS USING DICHROSTACHYS GLOMERATA TO REDUCE ANXIETY, FOOD CRAVINGS AND STRESS AND IMPROVE MOOD, PHYSICAL HEALTH, MENTAL HEALTH, ENERGY AND HAPPINESS IN A MAMMAL
Application US20260083794A1 Kind: A1 Mar 26, 2026
Inventors
Shil Kothari
Abstract
Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for improving mood in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
CPC Classifications
A61K 36/48 A61K 9/0053 A61P 25/22 A61P 25/24
Filing Date
2024-09-26
Application No.
18896891
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.